The Oncosearch | Oncotarget

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo Research Paper

Atif J. Khan, Stephanie LaCava, Monal Mehta, Devora Schiff, Aditya Thandoni, Sachin Jhawar, Shabbar Danish, Bruce G. Haffty, Suzie Chen

Published Apr 19, 2019 · Vol. 10, No. 29 · pp. 2824-2834

Keywords: glutamate, glioma, riluzole, radiation therapy

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

Kevin P. Kotredes, Roshanak Razmpour, Evan Lutton, Mercedes Alfonso-Prieto, Servio H. Ramirez, Ana M. Gamero

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2675-2692

Keywords: glioblastoma, IDH2, tumorigenesis, chemotherapy, biomarker

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

Dinoop Ravindran Menon, Mayumi Fujita

Published Apr 5, 2019 · Vol. 10, No. 27 · pp. 2583-2585

A novel anti-melanoma SRC-family kinase inhibitor Research Paper

Ruth Halaban, Antonella Bacchiocchi, Robert Straub, Jian Cao, Mario Sznol, Deepak Narayan, Ahmed Allam, Michael Krauthammer, Tarek S. Mansour

Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2237-2251

Keywords: melanoma, SRC-family kinase inhibitors, MAPK, MITF

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

Eloisa González-Lavado, Lourdes Valdivia, Almudena García-Castaño, Fernando González, Carmen Pesquera, Rafael Valiente, Mónica L. Fanarraga

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2022-2029

Keywords: nanomaterial, nanocarrier, drug delivery, combined therapy, microtubule dynamics

A global immune gene expression signature for human cancers Research Paper

Yuexin Liu

Published Mar 8, 2019 · Vol. 10, No. 20 · pp. 1993-2005

Implication of integrin Î±2Î²1 in anoikis of SK-Mel-147 human melanoma cells: a non-canonical function of Akt protein kinase Research Paper

Nadezhda I. Kozlova, Galina E. Morozevich, Natalia A. Ushakova, Albert E. Berman

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1829-1839

Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines Research Paper

Julia M. Kittler, Jonas Sommer, Anika Fischer, Sabine Britting, Margarete M. Karg, Barbara Bock, Imke Atreya, Ludwig M. Heindl, Andreas Mackensen, Jacobus J. Bosch

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1812-1828

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

Carla M.L. van Herpen, Sanjiv S. Agarwala, Axel Hauschild, Carola Berking, J. Thaddeus Beck, Dirk Schadendorf, Rob Jansen, Paola Queirolo, Paolo A. Ascierto, Christian U. Blank, Michael C. Heinrich, Rupam R. Pal, Adnan Derti, Victor Antona, Heidi Nauwelaerts, Angela Zubel, Reinhard Dummer

Published Mar 5, 2019 · Vol. 10, No. 19 · pp. 1850-1859

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors Research Paper

Baptiste Louveau, Julie Delyon, Coralie Reger De Moura, Maxime Battistella, Fanelie Jouenne, Lisa Golmard, Aurelie Sadoux, Marie-Pierre Podgorniak, Ichrak Chami, Oren Marco, Julie Caramel, Stephane Dalle, Jean-Paul Feugeas, Nicolas Dumaz, Celeste Lebbe, Samia Mourah

Published Mar 1, 2019 · Vol. 10, No. 18 · pp. 1669-1687

Risk stratification for melanoma Editorial

Catherine M. Olsen, David C. Whiteman

Published Feb 24, 2019 · Vol. 10, No. 20 · pp. 1868-1869

TGF-Î² inducible epithelial-to-mesenchymal transition in renal cell carcinoma Research Paper

Sandy Tretbar, Peter Krausbeck, Anja MÃ¼ller, Michael Friedrich, Christoforos Vaxevanis, Juergen Bukur, Simon Jasinski-Bergner, Barbara Seliger

Published Feb 19, 2019 · Vol. 10, No. 15 · pp. 1507-1524

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies Editorial

Laura HÃ¼ser, Peter Altevogt, Jochen Utikal

Published Feb 17, 2019 · Vol. 10, No. 18 · pp. 1662-1663

The interplay of CDK4 and CDK6 in melanoma Priority Research Paper

Karoline Kollmann, Coralie Briand, Florian Bellutti, Nikolaus Schicher, Stefan Blunder, Markus Zojer, Christoph Hoeller

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1346-1359

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, Joana Daradoumis, Christian Thirion, Peter Johannes Holst

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1458-1472

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

Steven A. Greenberg, Sek Won Kong, Evan Thompson, Stefano V. Gulla

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1399-1406

TERT promoter mutations in melanoma survival Editorial

Eduardo Nagore, Sivaramakrishna Rachakonda, Rajiv Kumar

Published Feb 12, 2019 · Vol. 10, No. 16 · pp. 1546-1548

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Michal Alon, Rand Arafeh, Joo Sang Lee, Sanna Madan, Shelly Kalaora, Adi Nagler, Tereza Abgarian, Polina Greenberg, Eytan Ruppin, Yardena Samuels

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1344-1344

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

Audrey Turchick, Yanfeng Liu, Weixi Zhao, Inessa Cohen, Peter M. Glazer

Published Feb 12, 2019 · Vol. 10, No. 13 · pp. 1272-1283

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper

Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Ines Silva, Robyn P.M. Saw, Kerwin Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer, James S. Wilmott

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 930-941

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo Research Paper

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

A novel anti-melanoma SRC-family kinase inhibitor Research Paper

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

A global immune gene expression signature for human cancers Research Paper

Implication of integrin Î±2Î²1 in anoikis of SK-Mel-147 human melanoma cells: a non-canonical function of Akt protein kinase Research Paper

Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines Research Paper

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors Research Paper

Risk stratification for melanoma Editorial

TGF-Î² inducible epithelial-to-mesenchymal transition in renal cell carcinoma Research Paper

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies Editorial

The interplay of CDK4 and CDK6 in melanoma Priority Research Paper

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

TERT promoter mutations in melanoma survival Editorial

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo Research Paper

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

A novel anti-melanoma SRC-family kinase inhibitor Research Paper

Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil Research Paper

A global immune gene expression signature for human cancers Research Paper

Implication of integrin Î±2Î²1 in anoikis of SK-Mel-147 human melanoma cells: a non-canonical function of Akt protein kinase Research Paper

Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines Research Paper

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma Research Paper

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors Research Paper

Risk stratification for melanoma Editorial

TGF-Î² inducible epithelial-to-mesenchymal transition in renal cell carcinoma Research Paper

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies Editorial

The interplay of CDK4 and CDK6 in melanoma Priority Research Paper

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

TERT promoter mutations in melanoma survival Editorial

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma Correction

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells Priority Research Paper

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas Research Paper